Literature DB >> 1984519

Life-threatening bullous skin eruptions during interleukin-2 therapy.

M R Staunton1, M C Scully, P E Le Boit, F R Aronson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1984519     DOI： 10.1093/jnci/83.1.56

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 2.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

3.  Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low-dose interleukin-2.

Authors:  M Engelhardt; J A Rump; U Hellerich; R Mertelsmann; A Lindemann
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

4.  Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

Authors:  J W Baars; J L Coenen; J Wagstaff; P van der Valk; H M Pinedo
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.